nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—LHCGR—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.0152	0.0682	CbGpPWpGaD
Goserelin—GNRHR—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.0102	0.0457	CbGpPWpGaD
Goserelin—GNRHR—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.00864	0.0387	CbGpPWpGaD
Goserelin—LHCGR—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.00851	0.0381	CbGpPWpGaD
Goserelin—LHCGR—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.008	0.0358	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00793	0.0355	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00604	0.027	CbGpPWpGaD
Goserelin—GNRHR—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.0057	0.0255	CbGpPWpGaD
Goserelin—LHCGR—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.00548	0.0246	CbGpPWpGaD
Goserelin—GNRHR—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.00536	0.024	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00531	0.0238	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.0048	0.0215	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00434	0.0195	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00404	0.0181	CbGpPWpGaD
Goserelin—GNRHR—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.00367	0.0164	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00366	0.0164	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00331	0.0148	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00322	0.0144	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00313	0.014	CbGpPWpGaD
Goserelin—GNRHR—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.00311	0.0139	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.0031	0.0139	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00297	0.0133	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00295	0.0132	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00291	0.013	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00268	0.012	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00252	0.0113	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00252	0.0113	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00245	0.011	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00226	0.0101	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00221	0.00992	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00207	0.00929	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00204	0.00916	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00202	0.00904	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00199	0.0089	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00192	0.00861	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00192	0.00861	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00192	0.0086	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00188	0.00841	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00183	0.0082	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.0018	0.00805	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00173	0.00775	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.0017	0.0076	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00169	0.00757	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00169	0.00757	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00151	0.00678	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00146	0.00655	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00137	0.00613	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00132	0.0059	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00129	0.00576	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00129	0.00576	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00129	0.00576	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00126	0.00563	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00123	0.00549	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00116	0.0052	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00116	0.00519	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00116	0.00517	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00114	0.00509	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00111	0.00497	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00111	0.00497	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00109	0.00486	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00109	0.00486	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00105	0.0047	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.001	0.00449	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000986	0.00442	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000986	0.00442	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000979	0.00438	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000882	0.00395	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000826	0.0037	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000814	0.00365	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000776	0.00348	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000773	0.00346	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00075	0.00336	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000744	0.00333	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000742	0.00333	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000742	0.00333	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000739	0.00331	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000727	0.00326	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000727	0.00326	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000702	0.00315	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000685	0.00307	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000676	0.00303	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000671	0.00301	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00066	0.00296	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00066	0.00296	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00062	0.00278	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000583	0.00261	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000583	0.00261	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000553	0.00248	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000545	0.00244	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000531	0.00238	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000502	0.00225	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000498	0.00223	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000495	0.00222	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000459	0.00205	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000452	0.00203	CbGpPWpGaD
Goserelin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000447	0.000576	CcSEcCtD
Goserelin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000447	0.000575	CcSEcCtD
Goserelin—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000447	0.000575	CcSEcCtD
Goserelin—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000446	0.000574	CcSEcCtD
Goserelin—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000446	0.000574	CcSEcCtD
Goserelin—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000446	0.000574	CcSEcCtD
Goserelin—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000446	0.000574	CcSEcCtD
Goserelin—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000444	0.000572	CcSEcCtD
Goserelin—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000444	0.000572	CcSEcCtD
Goserelin—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000444	0.000572	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000443	0.00199	CbGpPWpGaD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000443	0.00057	CcSEcCtD
Goserelin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000441	0.000567	CcSEcCtD
Goserelin—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000441	0.000567	CcSEcCtD
Goserelin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00044	0.000567	CcSEcCtD
Goserelin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00044	0.000567	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00044	0.000566	CcSEcCtD
Goserelin—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00044	0.000566	CcSEcCtD
Goserelin—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000437	0.000563	CcSEcCtD
Goserelin—Pain—Indinavir—acquired immunodeficiency syndrome	0.000437	0.000563	CcSEcCtD
Goserelin—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000437	0.000562	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000437	0.00196	CbGpPWpGaD
Goserelin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000437	0.000562	CcSEcCtD
Goserelin—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000437	0.000562	CcSEcCtD
Goserelin—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000436	0.000561	CcSEcCtD
Goserelin—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000435	0.00056	CcSEcCtD
Goserelin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000434	0.000559	CcSEcCtD
Goserelin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000434	0.000559	CcSEcCtD
Goserelin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000434	0.000559	CcSEcCtD
Goserelin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000434	0.000558	CcSEcCtD
Goserelin—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000433	0.000558	CcSEcCtD
Goserelin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000433	0.000557	CcSEcCtD
Goserelin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000433	0.000557	CcSEcCtD
Goserelin—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000432	0.000556	CcSEcCtD
Goserelin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000431	0.000555	CcSEcCtD
Goserelin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00043	0.000554	CcSEcCtD
Goserelin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00043	0.000554	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.00043	0.00193	CbGpPWpGaD
Goserelin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000429	0.000553	CcSEcCtD
Goserelin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000429	0.000552	CcSEcCtD
Goserelin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000429	0.000552	CcSEcCtD
Goserelin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000429	0.000552	CcSEcCtD
Goserelin—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000427	0.00055	CcSEcCtD
Goserelin—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000427	0.00055	CcSEcCtD
Goserelin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000426	0.000549	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000426	0.000548	CcSEcCtD
Goserelin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000425	0.000547	CcSEcCtD
Goserelin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000424	0.000546	CcSEcCtD
Goserelin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000421	0.000542	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000421	0.000542	CcSEcCtD
Goserelin—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00042	0.000541	CcSEcCtD
Goserelin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.00042	0.00054	CcSEcCtD
Goserelin—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00042	0.00054	CcSEcCtD
Goserelin—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000419	0.00054	CcSEcCtD
Goserelin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000419	0.00054	CcSEcCtD
Goserelin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000419	0.000539	CcSEcCtD
Goserelin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000418	0.000539	CcSEcCtD
Goserelin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000418	0.000538	CcSEcCtD
Goserelin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000418	0.000538	CcSEcCtD
Goserelin—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000418	0.000538	CcSEcCtD
Goserelin—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000417	0.000537	CcSEcCtD
Goserelin—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000416	0.000536	CcSEcCtD
Goserelin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000416	0.000536	CcSEcCtD
Goserelin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000416	0.000536	CcSEcCtD
Goserelin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000415	0.000534	CcSEcCtD
Goserelin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000415	0.000534	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000415	0.00186	CbGpPWpGaD
Goserelin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000415	0.000534	CcSEcCtD
Goserelin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000413	0.000532	CcSEcCtD
Goserelin—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000413	0.000532	CcSEcCtD
Goserelin—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000413	0.000532	CcSEcCtD
Goserelin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000413	0.000532	CcSEcCtD
Goserelin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000412	0.000531	CcSEcCtD
Goserelin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000412	0.00053	CcSEcCtD
Goserelin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000412	0.00053	CcSEcCtD
Goserelin—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000411	0.000529	CcSEcCtD
Goserelin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000411	0.000529	CcSEcCtD
Goserelin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00041	0.000528	CcSEcCtD
Goserelin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000409	0.000527	CcSEcCtD
Goserelin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000409	0.000527	CcSEcCtD
Goserelin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000409	0.000527	CcSEcCtD
Goserelin—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000409	0.000526	CcSEcCtD
Goserelin—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000408	0.000525	CcSEcCtD
Goserelin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000407	0.000524	CcSEcCtD
Goserelin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000407	0.000524	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000406	0.000523	CcSEcCtD
Goserelin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000406	0.000523	CcSEcCtD
Goserelin—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000405	0.000521	CcSEcCtD
Goserelin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000404	0.000521	CcSEcCtD
Goserelin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000404	0.00052	CcSEcCtD
Goserelin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000404	0.00052	CcSEcCtD
Goserelin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000403	0.000519	CcSEcCtD
Goserelin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000403	0.000519	CcSEcCtD
Goserelin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000403	0.000518	CcSEcCtD
Goserelin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000402	0.000518	CcSEcCtD
Goserelin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000402	0.000517	CcSEcCtD
Goserelin—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.0004	0.000515	CcSEcCtD
Goserelin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.0004	0.000515	CcSEcCtD
Goserelin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000399	0.000514	CcSEcCtD
Goserelin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000399	0.000514	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000399	0.00179	CbGpPWpGaD
Goserelin—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000399	0.000514	CcSEcCtD
Goserelin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000399	0.000513	CcSEcCtD
Goserelin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000398	0.000513	CcSEcCtD
Goserelin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000398	0.000513	CcSEcCtD
Goserelin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000398	0.000512	CcSEcCtD
Goserelin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000398	0.000512	CcSEcCtD
Goserelin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000397	0.000511	CcSEcCtD
Goserelin—Headache—Stavudine—acquired immunodeficiency syndrome	0.000396	0.00051	CcSEcCtD
Goserelin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000396	0.00051	CcSEcCtD
Goserelin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000396	0.000509	CcSEcCtD
Goserelin—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000395	0.000509	CcSEcCtD
Goserelin—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000395	0.000509	CcSEcCtD
Goserelin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000395	0.000508	CcSEcCtD
Goserelin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000394	0.000508	CcSEcCtD
Goserelin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000393	0.000506	CcSEcCtD
Goserelin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000392	0.000505	CcSEcCtD
Goserelin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000392	0.000505	CcSEcCtD
Goserelin—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000392	0.000505	CcSEcCtD
Goserelin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000392	0.000505	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000391	0.00175	CbGpPWpGaD
Goserelin—Headache—Abacavir—acquired immunodeficiency syndrome	0.00039	0.000502	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00039	0.00175	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00039	0.00175	CbGpPWpGaD
Goserelin—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00039	0.000502	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000389	0.000501	CcSEcCtD
Goserelin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000389	0.000501	CcSEcCtD
Goserelin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000389	0.000501	CcSEcCtD
Goserelin—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000386	0.000497	CcSEcCtD
Goserelin—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000386	0.000497	CcSEcCtD
Goserelin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000385	0.000495	CcSEcCtD
Goserelin—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000384	0.000495	CcSEcCtD
Goserelin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000384	0.000494	CcSEcCtD
Goserelin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000384	0.000494	CcSEcCtD
Goserelin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000384	0.000494	CcSEcCtD
Goserelin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000382	0.000491	CcSEcCtD
Goserelin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000382	0.000491	CcSEcCtD
Goserelin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000381	0.000491	CcSEcCtD
Goserelin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000381	0.00049	CcSEcCtD
Goserelin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000381	0.00049	CcSEcCtD
Goserelin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00038	0.000489	CcSEcCtD
Goserelin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000379	0.000488	CcSEcCtD
Goserelin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000378	0.000486	CcSEcCtD
Goserelin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000377	0.000485	CcSEcCtD
Goserelin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000377	0.000485	CcSEcCtD
Goserelin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000376	0.000484	CcSEcCtD
Goserelin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000376	0.000484	CcSEcCtD
Goserelin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000376	0.000483	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000375	0.000482	CcSEcCtD
Goserelin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000374	0.000481	CcSEcCtD
Goserelin—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000372	0.000479	CcSEcCtD
Goserelin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000371	0.000478	CcSEcCtD
Goserelin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00037	0.000476	CcSEcCtD
Goserelin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000369	0.000475	CcSEcCtD
Goserelin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000368	0.000474	CcSEcCtD
Goserelin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000367	0.000473	CcSEcCtD
Goserelin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000367	0.000472	CcSEcCtD
Goserelin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000367	0.000472	CcSEcCtD
Goserelin—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000367	0.000472	CcSEcCtD
Goserelin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000366	0.000471	CcSEcCtD
Goserelin—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000365	0.00047	CcSEcCtD
Goserelin—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000365	0.00047	CcSEcCtD
Goserelin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000365	0.00047	CcSEcCtD
Goserelin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000365	0.00047	CcSEcCtD
Goserelin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000363	0.000468	CcSEcCtD
Goserelin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000362	0.000466	CcSEcCtD
Goserelin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000362	0.000466	CcSEcCtD
Goserelin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000357	0.00046	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000357	0.00046	CcSEcCtD
Goserelin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000356	0.000458	CcSEcCtD
Goserelin—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000355	0.000457	CcSEcCtD
Goserelin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000355	0.000456	CcSEcCtD
Goserelin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000352	0.000454	CcSEcCtD
Goserelin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000352	0.000453	CcSEcCtD
Goserelin—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000352	0.000453	CcSEcCtD
Goserelin—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000352	0.000453	CcSEcCtD
Goserelin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00035	0.00045	CcSEcCtD
Goserelin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00035	0.00045	CcSEcCtD
Goserelin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000349	0.00045	CcSEcCtD
Goserelin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000349	0.00045	CcSEcCtD
Goserelin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000349	0.000449	CcSEcCtD
Goserelin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000346	0.000446	CcSEcCtD
Goserelin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000346	0.000446	CcSEcCtD
Goserelin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000346	0.000446	CcSEcCtD
Goserelin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000345	0.000445	CcSEcCtD
Goserelin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000344	0.000443	CcSEcCtD
Goserelin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000342	0.00044	CcSEcCtD
Goserelin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000341	0.000439	CcSEcCtD
Goserelin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00034	0.000438	CcSEcCtD
Goserelin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000339	0.000437	CcSEcCtD
Goserelin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000339	0.000436	CcSEcCtD
Goserelin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000338	0.000435	CcSEcCtD
Goserelin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000338	0.000435	CcSEcCtD
Goserelin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000338	0.000435	CcSEcCtD
Goserelin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000338	0.000435	CcSEcCtD
Goserelin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000336	0.000433	CcSEcCtD
Goserelin—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000335	0.000432	CcSEcCtD
Goserelin—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000335	0.000432	CcSEcCtD
Goserelin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000331	0.000427	CcSEcCtD
Goserelin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00033	0.000425	CcSEcCtD
Goserelin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000327	0.000421	CcSEcCtD
Goserelin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000327	0.000421	CcSEcCtD
Goserelin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000326	0.00042	CcSEcCtD
Goserelin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000325	0.000419	CcSEcCtD
Goserelin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000325	0.000419	CcSEcCtD
Goserelin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000325	0.000418	CcSEcCtD
Goserelin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000323	0.000416	CcSEcCtD
Goserelin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000322	0.000415	CcSEcCtD
Goserelin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000322	0.000414	CcSEcCtD
Goserelin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000321	0.000413	CcSEcCtD
Goserelin—Headache—Indinavir—acquired immunodeficiency syndrome	0.00032	0.000412	CcSEcCtD
Goserelin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000319	0.000411	CcSEcCtD
Goserelin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000316	0.000407	CcSEcCtD
Goserelin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000315	0.000405	CcSEcCtD
Goserelin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000312	0.000401	CcSEcCtD
Goserelin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00031	0.000399	CcSEcCtD
Goserelin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00031	0.000399	CcSEcCtD
Goserelin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000307	0.000395	CcSEcCtD
Goserelin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000307	0.000395	CcSEcCtD
Goserelin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000306	0.000393	CcSEcCtD
Goserelin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000304	0.000392	CcSEcCtD
Goserelin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000304	0.000392	CcSEcCtD
Goserelin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000304	0.000391	CcSEcCtD
Goserelin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000303	0.00039	CcSEcCtD
Goserelin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000302	0.000389	CcSEcCtD
Goserelin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000302	0.000389	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000297	0.00133	CbGpPWpGaD
Goserelin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000295	0.00038	CcSEcCtD
Goserelin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000294	0.000378	CcSEcCtD
Goserelin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000292	0.000376	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000292	0.00131	CbGpPWpGaD
Goserelin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000291	0.000375	CcSEcCtD
Goserelin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000291	0.000375	CcSEcCtD
Goserelin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000291	0.000375	CcSEcCtD
Goserelin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000289	0.000373	CcSEcCtD
Goserelin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000289	0.000372	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000288	0.00129	CbGpPWpGaD
Goserelin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000287	0.000369	CcSEcCtD
Goserelin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000283	0.000364	CcSEcCtD
Goserelin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000281	0.000362	CcSEcCtD
Goserelin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000281	0.000362	CcSEcCtD
Goserelin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000278	0.000357	CcSEcCtD
Goserelin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000274	0.000353	CcSEcCtD
Goserelin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000272	0.00035	CcSEcCtD
Goserelin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000272	0.00035	CcSEcCtD
Goserelin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000269	0.000347	CcSEcCtD
Goserelin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000269	0.000346	CcSEcCtD
Goserelin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000268	0.000346	CcSEcCtD
Goserelin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000268	0.000345	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000267	0.0012	CbGpPWpGaD
Goserelin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000261	0.000337	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000261	0.00117	CbGpPWpGaD
Goserelin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000259	0.000334	CcSEcCtD
Goserelin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000259	0.000334	CcSEcCtD
Goserelin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000259	0.000333	CcSEcCtD
Goserelin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000258	0.000332	CcSEcCtD
Goserelin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000254	0.000327	CcSEcCtD
Goserelin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000249	0.000321	CcSEcCtD
Goserelin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000247	0.000318	CcSEcCtD
Goserelin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000247	0.000318	CcSEcCtD
Goserelin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000246	0.000316	CcSEcCtD
Goserelin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000244	0.000314	CcSEcCtD
Goserelin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000233	0.0003	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000231	0.00103	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.00023	0.00103	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000154	0.000692	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000154	0.000688	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000136	0.000607	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.08e-05	0.000407	CbGpPWpGaD
